Umbilical cord blood infusion for low blood counts after chemo
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests whether infusing stem cells from umbilical cord blood can help your bone marrow recover and make healthy blood cells again after chemotherapy. The goal is to improve your blood counts and reduce the need for transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 80 years old.
- You have been diagnosed with myelodysplastic syndromes (MDS) or a certain type of leukemia (AML).
- You finished chemotherapy and your blood counts are still very low (grade 2 or higher bone marrow suppression).
- Your liver and kidney function are mostly normal (with some allowed mild elevations).
- Your heart function is normal, and you are able to do daily activities (ECOG 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving children their own or donor umbilical cord blood cells after chemotherapy can help their blood counts recover faster, allowing the next chemo round to start sooner. It's for children with solid tumors that have come back or not responded to treatment.
This study tests whether umbilical cord blood cells can help people whose blood counts stay dangerously low after immune-based cancer treatments like CAR-T or bispecific antibodies. The treatment aims to boost your blood cell recovery and reduce the need for transfusions.
This trial tests whether umbilical cord mesenchymal stem cell exosomes can help restore blood cell counts after chemotherapy in adults with acute myeloid leukemia who are in remission. It aims to reduce the risk of infection and bleeding while waiting for bone marrow recovery.
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
This trial tests whether umbilical cord blood can help raise platelet levels in people whose platelets drop after cancer treatment. If it works, it might reduce the need for platelet transfusions and lower bleeding risk.
This trial tests if umbilical cord stem cells can help restore low blood counts in people with leukemia, lymphoma, or myeloma who still have low blood cell levels three weeks after CAR-T therapy. It aims to improve recovery and reduce infection or bleeding risks.
Hear when a new Bone Marrow Suppression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.